These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
415 related items for PubMed ID: 20103818
1. New developments in the treatment of patients with multiple myeloma. Minnema MC, van der Spek E, van de Donk NW, Lokhorst HM. Neth J Med; 2010 Jan; 68(1):24-32. PubMed ID: 20103818 [Abstract] [Full Text] [Related]
3. Treatment of multiple myeloma: an emphasis on new developments. Kyle RA, Vincent Rajkumar S. Ann Med; 2006 Jan; 38(2):111-5. PubMed ID: 16581696 [Abstract] [Full Text] [Related]
5. Emerging drugs in multiple myeloma. Ghobrial IM, Leleu X, Hatjiharissi E, Hideshima T, Mitsiades C, Schlossman R, Anderson KC, Richardson P. Expert Opin Emerg Drugs; 2007 Mar; 12(1):155-63. PubMed ID: 17355220 [Abstract] [Full Text] [Related]
6. Further progress in the treatment of multiple myeloma? Malik PS, Kumar L. Natl Med J India; 2009 Mar; 22(1):25-7. PubMed ID: 19761157 [No Abstract] [Full Text] [Related]
7. "Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma. Gasparetto C, Gockerman JP, Diehl LF, de Castro CM, Moore JO, Long GD, Horwitz ME, Keogh G, Chute JP, Sullivan KM, Neuwirth R, Davis PH, Sutton LM, Anderson RD, Chao NJ, Rizzieri D. Biol Blood Marrow Transplant; 2010 Jan; 16(1):70-7. PubMed ID: 19733251 [Abstract] [Full Text] [Related]
8. Initial therapy in multiple myeloma: investigating the new treatment paradigm. Kettle JK, Finkbiner KL, Klenke SE, Baker RD, Henry DW, Williams CB. J Oncol Pharm Pract; 2009 Sep; 15(3):131-41. PubMed ID: 19276138 [Abstract] [Full Text] [Related]
17. [Bortezomib plus dexamethasone treatment followed by reduced-intensity allogeneic stem cell transplantation for multiple myeloma refractory to high-dose chemotherapy with autologous transplantation]. Hayashi T, Yasui H, Kawakami K, Ikeda H, Takahashi F, Kobayashi T, Nishimura S, Ishida T, Imai K, Shinomura Y. Rinsho Ketsueki; 2011 Mar; 52(3):136-41. PubMed ID: 21471701 [Abstract] [Full Text] [Related]
18. Bortezomib, thalidomide, and dexamethasone for relapsed multiple myeloma: add it up and wait. Badros A, Gahres N. Clin Adv Hematol Oncol; 2005 Dec; 3(12):916-7; discussion 918. PubMed ID: 16555432 [No Abstract] [Full Text] [Related]